Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
Mariano J. Alvarez, Prem S. Subramaniam, Laura H. Tang, et al.
Nature Genetics (2018) Vol. 50, Iss. 7, pp. 979-989
Open Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

A molecular single-cell lung atlas of lethal COVID-19
Johannes C. Melms, Jana Biermann, Huachao Huang, et al.
Nature (2021) Vol. 595, Iss. 7865, pp. 114-119
Open Access | Times Cited: 586
Epigenetic Therapies for Cancer
Susan E. Bates
New England Journal of Medicine (2020) Vol. 383, Iss. 7, pp. 650-663
Closed Access | Times Cited: 382
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages
Aleksandar Z. Obradovic, Nivedita Chowdhury, Scott M. Haake, et al.
Cell (2021) Vol. 184, Iss. 11, pp. 2988-3005.e16
Open Access | Times Cited: 247
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
Peter Horak, Christoph Heining, Simon Kreutzfeldt, et al.
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2780-2795
Open Access | Times Cited: 209
Phenotypic drug discovery: recent successes, lessons learned and new directions
Fabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 899-914
Open Access | Times Cited: 193
An expanded universe of cancer targets
William C. Hahn, Joel S. Bader, Theodore P. Braun, et al.
Cell (2021) Vol. 184, Iss. 5, pp. 1142-1155
Open Access | Times Cited: 179
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
Johannes Hofland, Gregory Kaltsas, Wouter W. de Herder
Endocrine Reviews (2019) Vol. 41, Iss. 2, pp. 371-403
Open Access | Times Cited: 158
Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies
Nikolas G. Balanis, Katherine M. Sheu, Favour N. Esedebe, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 17-34.e7
Open Access | Times Cited: 146
Multiple Endocrine Neoplasia Type 1: Latest Insights
Maria Luisa Brandi, Sunita Agarwal, Nancy D. Perrier, et al.
Endocrine Reviews (2020) Vol. 42, Iss. 2, pp. 133-170
Open Access | Times Cited: 144
A modular master regulator landscape controls cancer transcriptional identity
Evan Paull, Àlvaro Aytés, Sunny J. Jones, et al.
Cell (2021) Vol. 184, Iss. 2, pp. 334-351.e20
Open Access | Times Cited: 109
Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
Aleksandar Z. Obradovic, Diana Graves, Michael Korrer, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 10, pp. 2094-2109
Open Access | Times Cited: 109
A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution
Tianyu Zhu, Jacklyn Liu, Stephan Beck, et al.
Nature Methods (2022) Vol. 19, Iss. 3, pp. 296-306
Open Access | Times Cited: 78
Neuroendocrine Neoplasms of the Small Bowel and Pancreas
Ashley Kieran Clift, Mark Kidd, Lisa Bodei, et al.
Neuroendocrinology (2019) Vol. 110, Iss. 6, pp. 444-476
Open Access | Times Cited: 102
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications
Mauro Cives, Eleonora Pellè, Davide Quaresmini, et al.
Neuroendocrinology (2019) Vol. 109, Iss. 2, pp. 83-99
Open Access | Times Cited: 101
Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia
Yoshihiro Gocho, Jingjing Liu, Jianzhong Hu, et al.
Nature Cancer (2021) Vol. 2, Iss. 3, pp. 284-299
Open Access | Times Cited: 98
Comprehensive Genomic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Alberto Puccini, Kelsey Poorman, Mohamed E. Salem, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 22, pp. 5943-5951
Open Access | Times Cited: 82
Epigenetic landscape of pancreatic neuroendocrine tumours reveals distinct cells of origin and means of tumour progression
Annunziata Di Domenico, Christodoulos P. Pipinikas, Renaud Maire, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 77
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Yonghe Wu, Michael Fletcher, Zuguang Gu, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 71
A community challenge for a pancancer drug mechanism of action inference from perturbational profile data
Eugene F. Douglass, Robert J. Allaway, Bence Szalai, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 1, pp. 100492-100492
Open Access | Times Cited: 54
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Talya L. Dayton, Nicolas Alcala, Laura Moonen, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2083-2099.e9
Open Access | Times Cited: 35
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators
Aleksandar Z. Obradovic, Casey R. Ager, Mikko Turunen, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 933-949.e11
Open Access | Times Cited: 30
Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer
Jessica E. Hawley, Aleksandar Z. Obradovic, Matthew C. Dallos, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1972-1988.e5
Open Access | Times Cited: 26
A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies
Prabhjot S. Mundi, Filemon S. Dela Cruz, Adina Grunn, et al.
Cancer Discovery (2023) Vol. 13, Iss. 6, pp. 1386-1407
Open Access | Times Cited: 23
Genetic interactions reveal distinct biological and therapeutic implications in breast cancer
Cai-Jin Lin, Xi Jin, Ding Ma, et al.
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 701-719.e12
Closed Access | Times Cited: 8
Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators
Zhanyu Wang, Chengming Liu, Sufei Zheng, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1106-1125.e8
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top